TrialMedicina (Kaunas, Lithuania)2022

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.

Suhail Ahmad Mir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.